Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery.
暂无分享,去创建一个
S. Rogers | H. Boyes | J. Barraclough | R. Ratansi | A. Kanatas | H Boyes | J Barraclough | R Ratansi | S N Rogers | A Kanatas
[1] C. Bradford,et al. Development and validation of the neck dissection impairment index: a quality of life measure. , 2002, Archives of otolaryngology--head & neck surgery.
[2] P. Fayers,et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Rogers,et al. Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.
[4] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[5] G. Lockwood,et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. , 2005, International journal of radiation oncology, biology, physics.
[6] D. Jäger,et al. Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial , 2014, BMC Cancer.
[7] Tai-Lin Huang,et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. , 2008, International journal of radiation oncology, biology, physics.
[8] L. Dawson,et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. , 2003, International journal of radiation oncology, biology, physics.
[9] P. Levendag,et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. , 2009, International journal of radiation oncology, biology, physics.
[10] K. Courneya,et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors , 2008, Cancer.
[11] A. Balm,et al. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life , 2008, Radiation oncology.
[12] H. Seikaly,et al. Submandibular salivary gland transfer prevents radiation-induced xerostomia. , 2000, International journal of radiation oncology, biology, physics.
[13] Fei Liu,et al. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer , 2000, Supportive Care in Cancer.
[14] M. Parmar,et al. Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms , 1999, British Journal of Cancer.
[15] S. Singer,et al. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection , 2009, Head & neck.
[16] F. Hilgers,et al. First‐year quality of life assessment of an intra‐arterial (RADPLAT) versus intravenous chemoradiation phase III trial , 2009, Head & neck.
[17] E. Vokes,et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.
[18] Ulrich Keilholz,et al. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial. , 2015, The Lancet. Oncology.
[19] J. de Haes,et al. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.
[20] I. Barillot,et al. An international phase 3 trial in head and neck cancer: Quality of life and symptom results , 2014, Cancer.
[21] D. Brachman,et al. The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial , 2014, Quality of Life Research.
[22] G. Lockwood,et al. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[23] J. Wheeler,et al. Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07). , 2001, International journal of radiation oncology, biology, physics.
[24] R. Fisher,et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] L. Dawson,et al. Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer , 2003, World Journal of Surgery.
[26] D. Rischin,et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation , 2008, Journal of medical imaging and radiation oncology.
[27] W. Burke,et al. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. , 2008, Archives of otolaryngology--head & neck surgery.
[28] Robert L. White,et al. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. , 2003, International journal of radiation oncology, biology, physics.
[29] N. Husain,et al. Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma , 2015, Cancer biology & therapy.
[30] S. Rogers,et al. Structured review of papers reporting specific functions in patients with cancer of the head and neck: 2006 - 2013. , 2016, The British journal of oral & maxillofacial surgery.
[31] R. Frankowski,et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. , 2001, Archives of otolaryngology--head & neck surgery.
[32] A. Garden,et al. Long‐term functional and survival outcomes after induction chemotherapy and risk‐based definitive therapy for locally advanced squamous cell carcinoma of the head and neck , 2014, Head & neck.
[33] A. Negassa,et al. Radiofrequency ablation of advanced head and neck cancer. , 2011, Archives of otolaryngology--head & neck surgery.
[34] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[35] C. Bradford,et al. Head and neck cancer-specific quality of life: instrument validation. , 1997, Archives of otolaryngology--head & neck surgery.
[36] C. Terwee,et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study , 2010, Quality of Life Research.
[37] D. Robinson,et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] G. Lockwood,et al. Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] D. Ronis,et al. The effect of neck dissection on quality of life after chemoradiation , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[40] B. Noriega,et al. A pilot study of patient quality of life during radiation therapy treatment , 1994, Quality of Life Research.
[41] P. Ballmer,et al. Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: a randomized controlled trial. , 2013, Nutrition.
[42] L. Edgar,et al. Comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention. , 2006, The Journal of otolaryngology.
[43] A. Garden,et al. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] C. Leles,et al. Effect of intraoral low‐level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy , 2012, Head & neck.
[45] T. Whelan,et al. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[46] F. Rivera,et al. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial , 2009, Expert review of anticancer therapy.
[47] S. Kaasa,et al. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. , 1992, Acta oncologica.
[48] A. Carvalho,et al. Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy. , 2010, Archives of otolaryngology--head & neck surgery.
[49] F. Hirsch,et al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] Jan-Jakob Sonke,et al. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.
[51] S. Rogers,et al. A double blind randomised trial of IIb or not IIb neck dissections on electromyography, clinical examination, and questionnaire-based outcomes: a feasibility study. , 2012, The British journal of oral & maxillofacial surgery.
[52] E. Vokes,et al. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] D. Cella,et al. A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores , 2007, Quality of Life Research.
[54] I. M. Ventry,et al. The Hearing Handicap Inventory for the Elderly: a New Tool , 1982, Ear and hearing.
[55] A. Bottomley,et al. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323) , 2010, British Journal of Cancer.
[56] J. Hanson,et al. Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy , 2007, American journal of clinical oncology.
[57] C. V. van Hasselt,et al. Mode of treatment affects quality of life in head and neck cancer survivors: Implications for holistic care , 2010, Acta oto-laryngologica.
[58] I. Helenowski,et al. Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: A pilot study , 2015, Head & neck.
[59] L. Peters,et al. Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT‐staged T1‐2 N0 squamous cell carcinoma of the oral tongue , 2009, Head & neck.
[60] L. Eapen,et al. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] A. Dobson,et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.
[62] S. Rogers,et al. How will I be after my operation for oral cancer? , 2015, The British journal of oral & maxillofacial surgery.
[63] C. McConkey,et al. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. , 2016, The New England journal of medicine.
[64] K. Olivier,et al. Xerostomia in Long-term Survivors of Aggressive Non-Hodgkin's Lymphoma of Waldeyer's Ring: A Potential Role for Parotid-Sparing Techniques? , 2009, American journal of clinical oncology.
[65] P. Maguire,et al. Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.
[66] D. Kuik,et al. Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trial. , 2000, Clinical nutrition.
[67] C. Bokemeyer,et al. Patients and Methods: the European Organisation for Research and Treatment of Cancer Qol Questionnaire , 2022 .
[68] N. Sanfilippo,et al. Effects of exercise on swallowing and tongue strength in patients with oral and oropharyngeal cancer treated with primary radiotherapy with or without chemotherapy. , 2014, International journal of oral and maxillofacial surgery.
[69] A. Bezjak,et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis , 2005, Head & neck.
[70] M. Sullivan,et al. Quality-of-Life Effects of Psychosocial Intervention in Patients with Head and Neck Cancer , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[71] J. Machiels,et al. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy , 2014, BMC Cancer.
[72] E. Weymuller,et al. Assessment of quality of life in head and neck cancer patients , 1993, Head & neck.
[73] J. Mountz,et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. , 2009, International journal of radiation oncology, biology, physics.
[74] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[75] M. List,et al. A performance status scale for head and neck cancer patients , 1990, Cancer.
[76] S. Rogers,et al. Where do patients treated for oral cancer die? A 20-year cohort study 1992-2011. , 2015, The British journal of oral & maxillofacial surgery.
[77] R. Snaith,et al. The Hospital Anxiety and Depression Scale , 1983 .
[78] S. Soong,et al. A phase II study of topotecan in patients with recurrent head and neck cancer. Identification of an active new agent. , 1997, American journal of clinical oncology.